Surface-Modified Silica Hydrogels for the Programmable Release of Bisphosphonate Anti-Osteoporosis Drugs: The Case of Etidronate

Bisphosphonate drugs constitute the primary treatment for bone diseases such as Paget’s disease and osteoporosis. Despite their effectiveness, they also exhibit severe drawbacks, such as rapid excretion and limited oral bioavailability. High doses are usually administered to counterbalance these dra...

Descripción completa

Detalles Bibliográficos
Autores principales: Alatzoglou, Fanouria-Eirini G., Vassaki, Maria, Nirgianaki, Kalliopi, Tripodianos, Eleftherios, Turhanen, Petri, Demadis, Konstantinos D., Papathanasiou, Konstantinos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180253/
https://www.ncbi.nlm.nih.gov/pubmed/37176259
http://dx.doi.org/10.3390/ma16093379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10180253/
https://www.ncbi.nlm.nih.gov/pubmed/37176259
http://dx.doi.org/10.3390/ma16093379

Ejemplares similares